High-dose fulvestrant as third-line endocrine therapy for breast cancer metastasis to the left kidney
Dandan Xia(Wuxi People's Hospital), Junying Xu(Wuxi People's Hospital), Chaoying Liu(Electric Power University), Huiyu Wang(Wuxi No.2 People's Hospital), Runjie Wang(Wuxi No.2 People's Hospital)
Cited by 2
Related Papers
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|268
Theoretical Insight into High‐Efficiency Triple‐Junction Tandem Solar Cells via the Band Engineering of Antimony Chalcogenides
|Solar RRL|2021|117
Rotational design of charge carrier transport layers for optimal antimony trisulfide solar cells and its integration in tandem devices
|Solar Energy Materials and Solar Cells|2019|106